)
Edge10 Jul 2026
Inside Take-Two: The Grand Anticipation
The story of how Take-Two Interactive built the empire behind Grand Theft Auto, Red Dead Redemption, and one of gaming's largest mobile portfolios.
Pharmala Biotech
Pharmala Biotech (MDMA) investor relations material
Pharmala Biotech Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary29 Jul, 2026
Executive summary
Achieved significant revenue growth and improved financial position compared to 2025, driven by strong sales and strategic transactions.
Executed a notable transaction with Jupiter Neuroscience, announced in Q3 and completed in Q4.
Financial highlights
Revenue for the nine months ended May 31, 2026 reached over $1,000,000, up from $338,000 year-over-year; Q3 revenue was $513,000 versus $135,000 in Q3 2025.
Net loss for Q3 2026 was $499,759, and for the nine months was $1,247,150, both improved from $524,235 and $1,814,110 in the prior year periods.
Cash used in operating activities for the nine months was $673,588, down from $748,758 year-over-year.
Outlook and guidance
Licensing agreements are expected to provide further revenue opportunities and reflect the potential value of ongoing R&D.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Pharmala Biotech
- Revenue surged 10x year-over-year, with key patent and joint venture milestones achieved.MDMA
Q3 20245 May 2026 - Revenue up 95% with strong MDMA sales and new funding; distribution and U.S. growth drive outlook.MDMAQ1 20255 May 2026
- MDMA shipments and revenue rose, with operational gains and higher expenses from expansion.MDMAQ3 20255 May 2026
- Customer deposits and clinical trial pipeline grew, driven by Australian regulatory approvals.MDMAQ1 20265 May 2026
- Revenue up, losses down, and leadership changes mark a pivotal quarter in psychedelics commercialization.MDMAQ2 20265 May 2026
- Revenue surged 95% with improved EBITDA and a $1.56M private placement completed.MDMAQ4 202429 Dec 2025
- Customer deposits and clinical trial pipeline surged, fueled by Australian market expansion.MDMAQ4 202529 Dec 2025
- Revenue surged 95% year-over-year, with operational gains and expanded distribution.MDMAQ2 202529 Dec 2025
- MDMA therapy delivers rapid PTSD remission and global expansion, backed by innovation and strong IP.MDMASmall Cap Growth Virtual Investor Conference 202520 Oct 2025
Next Pharmala Biotech earnings date
Q4 202624 Dec, 2026
Pharmala Biotech
Next Pharmala Biotech earnings date
Q4 202624 Dec, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage